Follows adults with atrial fibrillation after heart rhythm catheter ablation
Studies what predicts atrial fibrillation returning after catheter ablation.
Plain-language title generated from the registry record
Registry title: PROSPective Evaluation of Outcome After CatheTer Ablation in Atrial Fibrillation
Key facts
- Where
- Lille, FranceSee the site
Where in France
- Institut Coeur-Poumon, CHULille, FranceTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- University Hospital, Lille
- Trial code
- NCT05009797
- Record updated
- 22 April 2026
- Original description
Atrial fibrillation ablation is the most common intervention performed worldwide. Up to 20 to 45% of patients show recurrence of AF within 12 month after catheter ablation, however its determinant are incompletely understood.Read full original descriptionShow less
PROSPective Evaluation of Outcome After CatheTer Ablation in Atrial Fibrillation : LONGITUDINAL STUDY OF PATIENTS UNDERGOING RADIOFREQUENCY ABLATION OF ATRIAL FIBRILLATION.
Atrial fibrillation ablation is the most common intervention performed worldwide. Up to 20 to 45% of patients show recurrence of AF within 12 month after catheter ablation, however its determinant are incompletely understood.
The aim of the PROSPECT-AF study is to assess the predictors of AF recurrence within the 3 years following ablation using clinical variables and innovative biomarkers in a prospective cohort of 750 patients undergoing atrial fibrillation catheter ablation.
The secondary aims are to assess the incidence of major adverse cardiovascular outcomes (MACE) and the incidence of major bleeding within the 3 years Wolfing catheter ablation.
Inclusion: Patient undergoing atrial fibrillation catheter ablation; Able to give their consent.
Exclusion: Childs; Patient under guardianship; Patients unable to give their consent; Pregnancy.